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ABSTRACT 
Introduction: There is considerable lack of awareness of newborn screening (NBS) among 
patients in the prenatal setting.  Only about 20 states have designed specific educational 
materials on NBS that are distributed during pregnancy.  Also, previous studies have shown that 
African American women receiving prenatal care believe that screening for sickle cell disease is 
beneficial, but they do not personally find themselves at an increased risk to have a child with 
sickle cell disease. To increase awareness of newborn screening and carrier screening for sickle 
cell disease, cystic fibrosis, and the thalassemias, we developed a website called My Baby’s 
Health.  This website provides education on NBS and carrier screening that is tailored to the 
patient’s ethnicity. The goal of this study is to evaluate this method of educating pregnant 
women on newborn screening and carrier testing.   
Methods: Women in their 1st or 2nd trimester of pregnancy were approached to access the My 
Baby’s Health website on a computer kiosk at the clinic. They were encouraged to take brief 
surveys before and after reading the information on the site.  The pre-website survey asked 
questions on the patient’s previous knowledge of sickle cell, cystic fibrosis, and the thalassemias, 
carrier testing, how these conditions are inherited, and how newborn screening is performed.  
The follow-up survey asked the same knowledge-based questions on the genetic conditions and 
newborn screening, as well as questions on the participant’s opinion of the site.  
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Results: Twenty-five participants completed both pre-and post-website surveys.  Knowledge of 
NBS and carrier testing did improve on the post-test, and all individuals found the website at 
least somewhat helpful. 
Conclusion: The website is helpful in increasing knowledge of sickle cell disease, and all 
participants found it at least somewhat useful.  However, one of the main challenges is 
implementing this website into the workflow of a clinic so that it has maximum benefit.  Using 
educational tools like this website may have a public health benefit by decreasing disparities in 
NBS services across the United States, since lack of awareness can lead to anxiety and failure to 
comply with recommendations for follow-up. 
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1.0  INTRODUCTION 
There is a significant lack of awareness of newborn screening in the United States [1].  To 
remedy this knowledge gap, the Genetic Alliance launched a website in September 2011 called 
“Baby’s First Test” (www.babysfirsttest.org), which gives patient-friendly information on the 
genetic conditions included on the newborn screening panel for each state.  This website also 
describes what to expect during the newborn screening process and provides resources in the 
event a baby tests positive for a condition.  With the support of Genetic Alliance, the website 
“My Baby’s Health” was developed to serve as a patient resource during the prenatal period. The 
goal of this project was to incorporate this website into the flow of a prenatal clinic and assess its 
efficacy in educating the prenatal population on newborn screening and carrier testing. 
1.1 MY BABY’ S HEALTH 
The My Baby’s Health website (www.mybabyshealth.org) is an educational tool that gives basic 
information on genetics, newborn screening and carrier testing for sickle cell disease, cystic 
fibrosis, and the thalassemias.  The first pages of the website describe the function of genes and 
how genetic testing is performed.  The participant is then able to select as many ethnic 
backgrounds as she identifies with (African American, Asian, Caucasian, Hispanic or Southeast 
Asian), and the website will provide information on screening for the genetic conditions most 
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commonly associated with that population.  Those of Caucasian ancestry receive information on 
cystic fibrosis, and all other ethnicities are presented information on sickle cell disease, alpha 
thalassemia, beta thalassemia, and cystic fibrosis.  Clinical features of the genetic conditions, 
what it means to be a carrier and autosomal recessive inheritance are all described. At the 
conclusion of the website, a basic overview of newborn screening is reviewed, describing how 
the test is performed and how the results are handled.  There is also a link to “Baby’s First Test”, 
so that viewers can look for more information specific to their state, including the specific 
genetic conditions included on that state’s panel.   
1.2 SPECIFIC AIM 1 
The first aim of this project was to integrate the “My Baby’s Health” website into the workflow 
of the prenatal clinic. 
1.3 SPECIFIC AIM 2 
The second aim of this project was to evaluate the impact of the “My Baby’s Health” website in 
educating pregnant women on the basics of newborn screening and carrier testing.   
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2.0  BACKGROUND AND SIGNIFICANCE 
2.1 NEWBORN SCREENING 
2.1.1 Overview 
Newborn screening is a mandatory public health program that began in the early 1960’s to 
identify genetic conditions that pose a significant health risk if left untreated and for which there 
is a treatment option available [2].  Phenylketonuria (PKU) was the first genetic condition to be 
screened for after Robert Guthrie developed the bacterial inhibition assay to measure blood 
phenylalanine levels as well as the filter paper for the blood spot test [3].  Over the years, 
newborn screening has expanded to include a wider range of genetic conditions. This testing is 
ideally conducted between 48-72 hours after birth by obtaining a blood sample through a heel 
stick. A hearing test is also part of the newborn screening process.   
All states in the United States perform newborn screening, but the specific regulations 
and the conditions included on the panel vary by state. In 2006, the American College of Medical 
Genetics (ACMG) issued a statement recommending 29 genetic conditions that should be 
included on every state’s newborn screening panel [4]. This Recommended Universal Screening 
Program (RUSP) is composed of conditions in the following categories: hemoglobinopathies, 
inborn errors of organic acid metabolism, fatty acid oxidation disorders, amino acid disorders, 
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and other miscellaneous diseases including congenital hypothyroidism and cystic fibrosis [2].  
States are not required to abide by these recommendations but can use them to inform their own 
NBS practices.  Since that time, the RUSP has expanded and includes 31 core conditions and 26 
secondary conditions as of December of 2012.  In order for a disorder to qualify for inclusion as 
a core condition on the RUSP, testing should be feasible in 24-48 hours after birth, have a 
treatment, and have a known natural history. It has become a key component of preventive 
pediatric medicine [5]. 
2.1.2 Educational gap 
Since newborn screening is mandatory, there is a concern for a lack of parental education.  When 
consent is required for a medical test, providers are required to, at the very least, inform parents 
that the test is being done and to obtain their permission.  The fact that NBS is mandatory does 
not mean the same level of parental education is not necessary, however data have shown that 
NBS is often not discussed with parents [3].   
It is well understood that parental education of newborn screening is essential, and most 
states have some type of educational measures in place [6].  Brochures outlining basic 
information are a common method of education.  Newborn screening is a complex system, and 
parents should be made aware of the basic procedures, significance of testing, possible outcomes, 
and the need for follow-up with a positive result [7].   
Davis et al discussed the findings of a focus group of parents and providers, which 
indicated that parents had very little familiarity with newborn screening [8].  Almost no parents 
had heard the term “newborn screening”, though some recalled a “heel stick test.” Some parents 
had heard of PKU, but were unaware that newborn screening tested for other genetic conditions 
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as well.  Most parents did not recall being given educational materials on newborn screening 
during the prenatal period.  Many said that they were given brochures after delivery, but few 
actually read them. [8] 
Bridging this educational gap is essential, as it has been suggested that if parents are 
aware of the purpose and process of screening, they may act more promptly if their child tests 
positive [9].  Additionally, if parents have been informed that a positive test result is not 
diagnostic and requires confirmatory testing, it may help lessen the stress of a false-positive 
result.  Tluczek et al found that parents whose newborn had an abnormal NBS result for cystic 
fibrosis had higher anxiety if they had less knowledge of newborn screening [10].  Finally, open 
communication on the process of newborn screening is important to promote confidence in this 
program as a public health initiative, particularly because there has been recent debate over the 
use of remaining blood spot samples for research purposes [9]. 
2.1.3 Integrating education into prenatal period 
Approximately 20 states require the distribution of newborn screening educational materials 
during the prenatal period [6]. However, in many cases, materials are distributed at inopportune 
times, such as after delivery [8].  The time period after delivery, when parents are exhausted and 
focused on the immediate needs of the newborn, is not optimal for a discussion on newborn 
screening.  There has also been evidence for a disparity in education depending on 
socioeconomic status.  Tluczek et al found that mothers with a lower income were more likely to 
receive newborn screening information after delivery than those with a higher income [11].   
Many studies have suggested that newborn screening is best discussed prenatally, but it is 
frequently not explained during that time period [1, 7, 8, 12].  Faulkner et al. found that only 
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33% of prenatal care providers discussed newborn screening with their patients [1].  Common 
factors limiting this discussion were that prenatal providers believed that pediatricians and other 
hospital staff would be the ones to explain newborn screening or that patients never inquired 
about it.  Hayeems et al. found that providers who felt a responsibility to discuss NBS with 
patients were three times more likely to do so, and those who lacked the confidence to counsel 
on NBS were 70% less likely to do so [12].  This data suggests that an educational tool, such as 
the My Baby’s Health website, containing all the pertinent information on NBS could help 
remove some barriers to patient education and help providers feel more equipped to discuss 
screening with their patients.  Having patients view the material during their clinic visit could 
take some of the responsibility off of the prenatal providers when they meet with patients, 
especially those who do not feel confident enough to explain NBS.    
2.2 CARRIER TESTING 
2.2.1 Sickle cell disease 
Sickle cell disease (SCD) is an inherited disorder characterized by the production of sickled 
hemoglobin.  This condition is caused by bi-allelic beta-S mutations in the HBB gene, which 
codes for the production of beta-globin [13].  Those with a mutation on only one allele are 
considered to have sickle cell trait (SCT).  Sickle cell disease can also occur if a beta-S mutation 
is inherited from one parent and a different beta-globin mutation is inherited from the other 
parent.  The most common examples of this compound heterozygosity are sickle cell-
hemoglobin C disease and sickle beta-thalassemia. Common features in affected individuals 
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include severe hemolytic anemia, pain crises, suppressed immune system, stroke, and 
organ/tissue damage, especially of the lungs, bones and kidneys [13].  This condition is 
particularly prevalent in those of African, South American, Central American, Saudi Arabian, 
Indian, and Mediterranean descent [14].  The Center for Disease Control (CDC) estimates that 
between 90,000 and 100,000 Americans are affected by SCD, and it occurs in 1 out of every 500 
Black or African-American births [14].  Approximately 1 in 12 African Americans has sickle 
cell trait [14].  Testing to determine if someone has SCT is performed using hemoglobin 
electrophoresis, which detects variations in types of hemoglobin in the bloodstream. 
 
2.2.2 Cystic Fibrosis 
Cystic Fibrosis (CF) is a multi-system disease that primarily affects the epithelial cells of the 
respiratory tract, hepatobiliary system, pancreas, intestine, and male genital tract [15].  It is an 
autosomal recessive condition caused by mutations in the CFTR gene, which controls the 
chloride channels of a cell. Improvements in treatment have increased the life expectancy of 
someone with cystic fibrosis to be about 37 years [15].  Cystic fibrosis is among the first genetic 
conditions to have a screening test for carrier status in the general population. It is most common 
in those of Caucasian or Ashkenazi Jewish descent, with carrier frequencies of 1:28 and 1:29 
respectively [15]. The ACMG has published screening guidelines that recommend screening the 
general population with a panel of 23 CFTR mutations [16].   
 8 
2.2.3 Alpha Thalassemia 
Alpha thalassemia is an autosomal recessive hemoglobinopathy that causes microcytic 
hypochromic anemia [17].  It is most prevalent in those of Mediterranean, South-East Asian, 
African, Middle Eastern, and Indian ancestry [18].  There are two clinically significant 
presentations: hemoglobin Bart hydrops fetalis (Hb Bart syndrome) and hemoglobin H disease.  
Hb Bart syndrome is the most severe form of alpha thalassemia and typically is fatal in the 
neonatal period.    Hemoglobin H disease is typically associated with anemia, mild jaundice, 
hepatosplenomegaly, and some bone abnormalities [17].   
2.2.4  Beta Thalassemia 
Beta thalassemia is a blood condition characterized by reduced production of hemoglobin, 
causing microcytic hypochromic anemia [19].  There are two main classifications: major and 
minor thalassemia.  Thalassemia major usually presents within the first 2 years of life, with 
symptoms including failure to thrive, jaundice, and enlarged spleen and liver.  This condition can 
also cause bone deformity and delayed puberty.  Thalassemia intermedia is less severe and 
typically manifests later in life.  Symptoms can include anemia, bone changes, and 
hepatosplenomegaly.  Beta thalassemia occurs most frequently in those from Mediterranean 
countries, North Africa, the Middle East, Indian, Central Asia, and Southeast Asia.     
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2.2.5 Perceptions of sickle cell disease and carrier testing 
Previous studies have suggested that the African American community perceives sickle cell as a 
serious disease, but individuals generally do not believe they have a significant risk to have a 
child with that condition.  Further, there is relatively low uptake of education of sickle cell 
disease.  Some barriers to this education include a desire for avoidance, since some believe that 
not thinking about genetic conditions makes it less likely for them to occur [20].   Long and 
colleagues conducted a focus group of African American individuals to elucidate their perception 
of SCD and SCT, as well as carrier testing and newborn screening [20].  That study found that 
there is a perceived benefit to carrier testing and newborn screening, because of the value in 
being aware of a child having a medical condition in advance and having the option to choose 
whether to continue a pregnancy.   
In the African American community, it is common to rely on personal or secondhand 
experiences when understanding the genetics of sickle cell disease [20].  Using friends and 
family as the primary source of information increases the chance of being misinformed.  Further, 
it has also been shown that African-American women were 50-70% less likely to use health 
information resources such as news media and computers [21].  Increasing the utilization of 
health resources, such as websites like My Baby’s Health, can reduce the likelihood of 
individuals being misinformed about genetics and specific genetic conditions. 
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2.2.6 Benefits of prenatal education on carrier testing 
As with newborn screening, education on carrier testing has been suggested to improve follow-
up if a carrier test comes back positive.  Generally, the follow-up rate for those with sickle cell 
disease, sickle cell trait, and other hemoglobinopathies ranges between 35 to 60 percent in the 
United States [22].  Potential factors that hinder follow-up include anticipatory anxiety, guilt, and 
denial of having a child with a health problem.  It has been shown that education during the 
prenatal period improves follow-up for those with sickle cell trait [22].    
2.3 PATIENT EDUCATION 
2.3.1 Computer Education 
Computer education has emerged as a way to make medical information more accessible to 
patients in a more cost-effective way.  These computer programs can be more interactive than 
paper materials, allowing patients to have stronger improvement in knowledge and to have more 
involvement in medical decision-making [23]. Individuals have differing baseline levels of 
knowledge, so it can be challenging to develop a program that is appropriate for a wide range of 
people.  Multiple studies have found that those from rural areas and a lower socioeconomic 
status tend to respond well to computer-based education, suggesting that the My Baby’s Health 
website could be a useful tool to educate that population [23].   Learning from a website allows 
individuals to read through the information at their own pace, which can be beneficial for those 
with lower literacy skills.  Keulers et al found that retained knowledge may be even higher for 
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those who were educated through a computer rather than by a provider, and that patient 
satisfaction was equal for both methods [24].   
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3.0  METHODS AND PROCEDURES 
3.1 PARTICIPANT RECRUITMENT 
Participants were recruited from the Outpatient Clinic at Magee-Women’s Hospital of University 
of Pittsburgh Medical Center from August 2012 to February 2013.  Women who were in their 
first or second trimester of pregnancy at their first obstetrical visit were eligible.  They were 
approached after having their blood work drawn at the end of their clinic visit.  They were taken 
to a computer kiosk in the clinic with a link to the My Baby’s Health website.  Exclusion criteria 
included women who were under the age of 18, did not speak or read English, or were 
incarcerated.   
3.2 CONSENT 
Before taking the surveys, participants can read through a paragraph describing the goal of the 
study.  The paragraph states that their participation is voluntary and that they may withdraw at 
any time.  There were no foreseeable risks to completing the surveys.  Contact information for 
study personnel was provided.  See Appendix A for the consent paragraph. 
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3.3 COMPENSATION 
Participants were offered a free water bottle after viewing the website if they completed both 
surveys. 
3.4 PRE-AND POST-WEBSITE SURVEYS 
The pre-website survey was composed of one question asking which genetic conditions the 
participant had heard of, six knowledge-based questions and six questions on demographic 
information.  The post-website survey had the same six knowledge-based questions, as well as 
five opinion-based questions on the helpfulness of the website.  Surveys were taken 
anonymously.  See Appendix A for the survey questions. 
3.5 STATISTICAL ANALYSIS 
The knowledge-based portion of the survey results was analyzed using non-parametric tests to 
determine if participants had improved performance on the post-website test.  Non-parametric 
tests were used under the assumption that the data would not follow a normal distribution.  Test 
scores were also compared with age and number of other children to evaluate the effect of those 
factors.  Finally, the data were stratified by race to determine if there is any evidence suggestive 
of culture bias in the website.  Other demographic data including education level and relationship 
status were also evaluated in their relationship with test scores.   
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4.0  RESULTS 
A total of 34 women took the pre-website survey, and 31 took the post-website survey.  Twenty-
five took both surveys.  Statistical analyses were conducted only on those who completed both 
surveys. 
4.1 PATIENT POPULATION DEMOGRAPHICS 
Out of the 25 participants who took both surveys, the age range was from 18-36, with a 
mean age of 22.8 years.  Figures 1-4 below describes the educational background, relationship 
status, number of previous children, and ethnic background of those who completed the surveys. 
Figure 1. Participants’ Educational Background 
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Figure 2. Study Population Relationship Status 
Figure 3.  Study Participants’ Number of Prior Children 
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Figure 4. Participants' Ethnic Background 
4.2 PRE- AND POST-WEBSITE SURVEYS 
4.2.1 Prior Familiarity with Genetic Conditions and NBS 
Figure 5 below depicts the participants’ familiarity with sickle cell trait and disease, the 
thalassemias, cystic fibrosis, and newborn screening prior to viewing the website.  Thalassemia 
was the condition with which participants were least familiar (36%), and there was the most prior 
familiarity with sickle cell disease (68%).  Over half (60%) of participants had heard of newborn 
screening. 
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Figure 5.  Participants Prior Familiarity with Genetic Conditions and Newborn Screening 
4.2.2 Post-test vs. Pre-test Performance 
To compare scores on pre- and post-tests, the Wilcox test for paired data was performed with a 
one-sided p-value.   The null hypothesis was that there would be no difference in performance 
between the two surveys, with the alternative hypothesis that scores on the post-test would be 
improved over the pre-test.  Scores were shown to be higher on the post-test, with a total p-value 
of 0.000667.  When divided into individual questions, there was statistically significant 
improvement on questions 1, 2, 4, and 5.  The results of this analysis are summarized in Table 1 
below. 
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Table 1. Pre-Test and Post-Test Performance (n=25) 
Survey Question Correct Responses on 
Pre-Website Survey 
Correct Responses on 
Post-Website Survey 
P-Value 
What does a positive sickle 
cell carrier test mean? 
8 (32%) 16 (64%) 0.01176 
How can a child get SCD? 7 (28%) 18 (72%) 0.001301 
What does a negative CF 
carrier test mean? 
6 (24%) 10 (40%) 0.09083 
T/F: Two parents who are 
CF carriers can have healthy 
children 
9 (36%) 17 (68%) 0.006712 
How is NBS performed? 10 (40%) 22 (88%) 0.000314 
T/F: A healthy baby can 
receive an abnormal NBS 
result 
10 (40%) 15 (60%) 0.07252 
Average total score 2 4 0.0000677 
McNemar’s chi square test for paired data was conducted to evaluate each test question 
individually.  The null hypothesis for this two-sided test was that there would be no difference 
between performances on each test, while the alternative was that there was a difference (not 
necessarily an improvement).   This test also found a statistically significant difference in scores 
on questions 1, 2, 4, and 5.  The p-values are listed in Table 2 below. 
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Table 2. Change from pre-test to post-test 
Question Number P-Value 
1 0.04331 
2 0.005546 
3 0.2888 
4 0.02686 
5 0.001496 
6 0.2278 
Both the Wilcox and McNemar test were used because of the individual strengths and 
weaknesses of these tests.  Wilcox allows a one-sided test, which provides higher statistical 
power for the question at hand since we are specifically looking for an improvement in the post-
test over the pre-test score.  However, with this test the symmetry assumption of the distribution 
may not necessarily be upheld.  McNemar’s test is ideal for testing independence of paired 
binary variables, but this can only be a two-sided test and would therefore have reduced 
statistical power. 
4.2.3 Test Performance vs. Age 
Using the Spearman correlation between pre- and post-test total score and age, it was found that 
age had no correlation with the performance on the pre-test.  However, there was a statistically 
significant relationship between age and the score on the post-test.  There was an inverse 
relationship, where the score on the post-test decreased as the participant’s age increased.  These 
findings are shown in Table 3 and Figures 6 and 7.   
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Table 3. Age vs. Test Performance 
Test Rho P-Value 
Pre-test total -0.082956 0.6934 
Post-test total -0.525623 0.006967 
Change 
(post-test total – pre-test total) 
-0.42421 .03456 
Figure 6.  Pre-test vs. Age 
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Figure 7. Post Test vs. Age 
To evaluate if the number of other children influenced this age effect, the Spearman correlation 
was re-calculated adjusting for previous children.  Table 4 contains the analysis while adjusting 
for either having or not having any previous children.  Table 5 adjusts for the number (1-4) of 
previous children.  The age effect was still present even when accounting for having other 
children. 
Table 4.  Age vs. Test Performance (adjusted for having had previous children) 
Test Rho P-Value 
Pre-test total -0.29971 0.1455 
Post-test total -0.47762 0.01575 
Change  
(post-test total – pre-test total) 
-0.31627 0.1235 
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Table 5.  Age vs. Test Performance (adjusted for the number of previous children) 
Test Rho P-Value 
Pre-test total -0.18097 0.3867 
Post-test total -0.60918 0.001229 
Change 
(post-test total – pre-test total) 
-0.43435 0.03004 
4.2.4 Test Performance vs. Having Previous Children 
The effect of having had prior children was measured against pre- and post-test performance 
using the Mann-Whitney test.  Those who claimed to have one or more previous children were 
compared with those who have never had a child.  The analysis showed that those with at least 
one other child did better on the pre-test, but there was no difference in post-test performance.  
The results are listed in Table 6 below. 
Table 6. Previous Children vs. Test Performance 
Prior Children Test P-Value 
Previous children vs. none Pre-Test 0.04767 
Post-Test 0.9338 
Change 0.02677 
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4.2.5 Test Performance and Other Demographic Factors 
Pre-and Post-test performances were compared with other demographics including race, 
educational background, and relationship status.  The impact of ethnicity was analyzed using the 
Mann-Whitney test with a two-side p-value.  For ethnicity, almost all individuals identified 
themselves as either African American or Caucasian. There were two individuals who called 
themselves both Caucasian and African American, as well as one person who was American 
Indian/Alaska Native.  Race was analyzed in two ways, which differed in the way participants 
who were biracial or American Indian/Alaska Native were treated. In the first analysis, those 
who considered themselves only Caucasian were compared to all other ethnicities.  Second, 
those who identified as African American, even if they also selected another ethnicity, were 
compared with those who did not say they were African American.  There was no statistically 
significant difference in scores between ethnic groups.   There was a nearly significant difference 
(p=0.06984) in the pre-test score between African Americans and non-African Americans, so it 
is possible that there is a race difference in knowledge before reading the website.  There was no 
evidence for a difference in post-test performance. Therefore, if race is associated with 
differences in previous awareness of genetic conditions and newborn screening, the website may 
make up for any deficiency in knowledge.  Table 7 below summarizes these findings. 
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Table 7.  Race vs. Test Performance 
Race Test P-Value 
Caucasian vs. not Caucasian Pre-Test 0.2456 
Post-Test 0.7952 
Change 0.1666 
African American vs. not 
African American 
Pre-Test 0.06984 
Post-Test 0.8246 
Change 0.1749 
The scores of those in a relationship (stating they were either in a relationship or married) were 
compared to those who were not in a relationship (single or divorced).  There was no difference 
in scores between the two groups, as shown in Table 8. 
Table 8. Relationship Status vs. Test Performance 
Relationship Status Test P-Value 
In a relationship/married vs. 
single 
Pre-Test 0.7652 
Post-Test 0.09656 
Change 0.4234 
The role of a participant’s educational background was compared to test performance to 
determine if those with a college background (either completing some college or having a 
college degree) scored differently than those who did not attend college at all (some high school 
or a high school degree).  There was no statistically significant difference in test scores, as shown 
by Table 9. 
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Table 9. Educational Background vs. Test Performance 
Educational Background Test P-Value 
College vs. none Pre-Test 0.2528 
Post-Test 0.618 
Change 0.3057 
4.2.6 Opinion-based Questions 
The following graphs (figures 8-11) describe the participants’ feedback on the website, which 
was overwhelmingly positive.  The vast majority of individuals (92%) said the website provided 
just the right amount of information.  Additionally, 64% of participants found the information to 
be clearly presented, found it helpful in understanding genetic testing and NBS, and believed it 
better prepared them to discuss that testing with their prenatal care providers.   The remainder of 
participants found the website to be somewhat clear and somewhat helpful in learning the 
information.  Finally, 76% of participants would recommend the website to other women, and 
the remainder would consider recommending it.  
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5.0  DISCUSSION 
5.1 SPECIFIC AIM 1 
The aim of implementing this website into the workflow of the clinic had limited success.  The 
clinic has a high volume of patients, which made it challenging to incorporate this website 
consistently into patients’ clinic visits.  For this study, patients were shown the website at the end 
of their time in clinic, after they had seen all their providers and had their blood drawn in the lab.   
This is not the ideal time for them to see the website, since they would have already seen their 
prenatal care providers and were frequently tired from spending a few hours in clinic. It would 
have been preferred for a patient to read through the website before meeting with her 
obstetrician, since she would then have the opportunity to ask questions and it could potentially 
cut down on the provider’s counseling time.   
5.2 SPECIFIC AIM 2 
The effectiveness of this website was successfully evaluated.  The data indicate that it is helpful 
in improving women’s knowledge of genetics and newborn screening, shown both by 
improvement in knowledge-based questions from a pre- to post-test and by opinion-based 
questions.  On average, participants answered as many questions correctly on the post-test, and 
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their feedback was overwhelmingly positive.  All participants believe the website was at least 
somewhat helpful in helping them understand genetic testing and newborn screening.  
Differences in race, educational level, and relationship status had no statistically significant 
impact on a participant’s score.  The fact that there was no evidence of a culture bias in the 
website is important, particularly for the African-American population since there is a history of 
mistrust of medical professionals [25].  It has been shown that younger individuals have a 
general wariness of physicians, even though they have never heard of events such as the 
Tuskegee Syphilis study.  It has been suggested that this sentiment has been ingrained into the 
African American culture and is passed down through generations [25].  When there is mistrust 
of health care providers, a website reinforcing information could be useful as an additional 
means of education.   
The only factors that had a significant effect on score were the participant’s age and 
number of previous children.  Age had an inverse correlation with score on the post-test, but had 
no impact on performance on the pre-test.   All participants were relatively young (mean age of 
22 years), therefore it seems unlikely that older individuals would have less experience with 
technology so that their scores would be lower.  This analysis was re-calculated to adjust for 
previous children, and the age difference was still present.  A larger sample size with a balance 
of older participants could be helpful to determine how significant this difference is. 
The number of previous children had an impact on pre-test score, but not on the post-test.  
The pre-test score was higher for those with other children, but they did not score any better on 
the post-test.  This suggests that mothers had some familiarity with newborn screening and 
carrier testing from previous pregnancies.  Since there was no difference in post-test scores, it 
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could be that reading the website brings the new moms’ knowledge up to the level of someone 
with previous children.     
5.3 STUDY LIMITATIONS 
Though the findings of this study have allowed this educational tool to be evaluated, there are 
some limitations.  One of the main limitations is that those who were Caucasian did not see 
information on sickle cell disease while reading the website, but two of the survey questions 
were on sickle cell disease.  Therefore, these individuals were being tested on information to 
which they weren’t exposed.  The sample size of 25 participants was relatively small, and more 
participants could have provided additional strength to the findings.  It was also difficult to 
assess if this website is a practical tool for this clinic, since patients never went to the website 
unless they were approached and personally led to it.  It was a challenge to implement this 
website into the natural flow of the clinic and for patients to view the information at the most 
opportune time.   
 
5.4 AREAS FOR FUTURE STUDY 
Given that there was difficulty in implementing the website in the clinic, further study could be 
done to evaluate the website in a different clinical setting, such as a private practice.   If a clinic 
has success in incorporating the website so that women see it prior to meeting with their 
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physician, it would be interesting to compare how much having read the website affects their 
conversation with the obstetrician.  Once the website has become consistently utilized in a clinic, 
individuals who either test positive on a carrier screen or have a newborn with a positive 
screening result can be surveyed to determine if they were familiar with My Baby’s Health, and 
if learning about NBS and carrier testing in the prenatal period was helpful.  Additional analysis 
could be done to determine if people who found the website “somewhat helpful” or “somewhat 
clear” did more poorly on the post-test.  Separate surveys could also be developed for those who 
are Caucasian so that this population is not tested on information they did not see while reading 
the website. 
5.5 CONCLUSION 
The data indicate that the My Baby’s Health website is a useful tool in improving knowledge on 
carrier testing and newborn screening.  This website would be most beneficial if it were 
incorporated into the natural flow of the clinic, so that all prenatal patients are encouraged to 
visit the website while waiting to meet with the provider.  Exposure to carrier testing and 
newborn screening beforehand could reduce the time a provider would need to spend counseling 
on that information. Since increased patient knowledge of carrier testing and NBS has been 
suggested to improve follow-up, this website can help newborns who have tested positive to 
receive more timely management.  Improved education also has the benefit of reducing anxiety 
that accompanies a positive newborn or carrier screening test.  If utilized to its full potential in 
numerous prenatal clinics across the United States, the My Baby’s Health website could have 
public health impact.  It could decrease health disparities across the country by making education 
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on newborn screening and carrier testing more accessible to a wider array of individuals, 
including those of different socioeconomic and ethnic backgrounds. 
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APPENDIX A: SURVEYS 
A.1 PRE-WEBSITE SURVEY 
 
Dear Viewer, 
 
The purpose of this research study is to determine whether a website can effectively provide 
education about genetics and testing to pregnant women.  We plan to survey women who have 
an appointment with a prenatal care provider during their pregnancy.  The two questionnaires are 
brief (totaling 5-10 minutes) and will be presented before and after the website is viewed.  
If you are willing to participate, our questionnaire will ask you about genetic testing and genetic 
diseases, as well as about your background (e.g., age, education, race).  There are no foreseeable 
risks associated with this survey.  There are no direct benefits to you and you will not receive 
payment for participating.  Your participation is voluntary, and you may withdraw at any time. 
This study is being conducted by Dr. Lakshmanan Krishnamurti, a pediatric hematologist, and 
Claire Harwood, BA, a genetic counseling intern.  The study personnel can be reached at 412-
692-7827, if you have any questions. 
Genetics and Testing 
These 7 questions are about what you may have heard about genetic conditions 
and testing. 
1.  Have you heard of any of the following conditions or tests? Check all that apply. 
  Sickle cell trait 
  Sickle cell disease 
  Cystic fibrosis (CF) 
  Thalassemia 
  Newborn screening 
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  I have not heard of any of these 
 
2.  A positive sickle cell carrier test means:  
o  That person definitely has sickle cell trait 
o  That person probably has sickle cell trait 
o  That person could develop sickle cell trait over time 
o  There is no test for sickle cell trait 
o  Don't know 
 
 
3.  How can a child get sickle cell disease?  
o  Both parents must have sickle cell trait 
o  Their mom has sickle cell trait but their dad does not 
o  Their dad has sickle cell trait but their mom does not 
o  One parent also has sickle cell disease 
o  Don't know 
 
4.  A negative cystic fibrosis carrier test means:  
o  That person is definitely not a carrier 
o  That person is probably not a carrier, although this cannot be definitely ruled out 
o  There is no carrier test for cystic fibrosis 
o  Don't know 
 
 
5.   If two parents are carriers for cystic fibrosis, they can have healthy children.  
o  True 
o  False 
o Don't know 
 
6.  How is newborn screening performed?  
o  The baby goes to a check-up with a doctor 
o  The baby's blood is drawn by pricking their heel 
o  The baby's blood is drawn from their arm 
o  The baby's DNA is taken from their saliva 
o  Don't know 
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7.  A healthy baby can receive a positive (abnormal) newborn screening result.  
o  True 
o  False 
o  Don't know 
 
 
A.2 POST-WEBSITE SURVEY 
These 6 questions are about what you may have heard about genetic conditions 
and testing. 
 
 
A positive sickle cell carrier test means:  
o  That person definitely has sickle cell trait 
o  That person probably has sickle cell trait 
o  That person could develop sickle cell trait over time 
o  There is no test for sickle cell trait 
o  Don't know 
 
 
How can a child get sickle cell disease?  
o  Both parents must have sickle cell trait 
o  Their mom has sickle cell trait but their dad does not 
o  Their dad has sickle cell trait but their mom does not 
o  One parent also has sickle cell disease 
o  Don't know 
 
 
A negative cystic fibrosis carrier test means:  
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o  That person is definitely not a carrier 
o  That person is probably not a carrier, although this cannot be definitely 
ruled out 
o  There is no carrier test for cystic fibrosis 
o  Don't know 
 
 
If two parents are carriers for cystic fibrosis, they can have healthy children.  
o  True 
o  False 
o  Don't know 
 
 
How is newborn screening performed?  
o  The baby goes to a check-up with a doctor 
o  The baby's blood is drawn by pricking their heel 
o  The baby's blood is drawn from their arm 
o  The baby's DNA is taken from their saliva 
o  Don't know 
 
 
A healthy baby can receive a positive (abnormal) newborn screening result.  
o  True 
o  False 
o  Don't know 
 
 
These 5 questions tell us how you felt about the MyBabysHealth.org website. 
 
Would you say the amount of information provided by the website was: * 
o  Too little 
o  Just right 
o  Too much 
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Would you say the information on the website was:  
o  Not at all clear 
o  Somewhat clear 
o  Very clear 
 
 
How helpful would you say this website was in helping you understand genetic 
testing and newborn screening?  
o  Not at all helpful 
o  Somewhat helpful 
o  Very helpful 
 
 
How helpful would you say this website was in preparing you to discuss prenatal 
genetic testing with your provider?  
o  Not at all helpful 
o  Somewhat helpful 
o  Very helpful 
 
 
Would you recommend that other women use this website before visiting their 
providers?  
o  Never recommend 
o  Might recommend 
o  Would recommend 
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